Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-25T06:41:45.405Z Has data issue: false hasContentIssue false

Chapter 17 - Breastfeeding and Use of Antiseizure Medications

Published online by Cambridge University Press:  19 December 2024

By
Abrar O. al-Faraj  and
Trudy D. Pang
Edited by
Esther Bui  and
P. Emanuela Voinescu
Esther Bui
Affiliation:
Toronto Western Hospital
P. Emanuela Voinescu
Affiliation:
Brigham & Women's Hospital, Boston, MA
Get access

Summary

The literature regarding breastfeeding and effects of anti-seizure medication (ASM) exposure via breastmilk has evolved over the past two decades, with mounting evidence that supports breastfeeding for women with epilepsy (WWE) taking ASMs. In this chapter, we provide an overview of the current evidence that supports breastfeeding in infants of mothers taking ASM; safety profile of each ASM and reported adverse effects for various ASMs. Lastly, we review rates and patterns, as well as potential barriers to breastfeeding in WWE and potential intervention to improve breastfeeding practices in WWE.

Keywords

Breastfeedinganti-seizure medicationneurodevelopmentwomen with epilepsycounsellingdrug exposure
Type
Chapter
Information
Women with Epilepsy
A Practical Management Handbook
 , pp. 279 - 292
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Harden, CL, Pennell, PB, Koppel, BS, et al. Practice parameter update: Management issues for women with epilepsy. Focus on pregnancy (an evidence-based review). Vitamin K, folic acid, blood levels, and breastfeeding. Neurology. 2009;73(2):142–9.CrossRefGoogle ScholarPubMed
Johnson, EL, Burke, AE, Wang, A, Pennell, PB. Unintended pregnancy, prenatal care, newborn outcomes, and breastfeeding in women with epilepsy. Neurology. 2018;91(11):1031–9.CrossRefGoogle ScholarPubMed
al-Faraj, AO, Pandey, S, Herlihy, MM, Pang, TD. Factors affecting breastfeeding in women with epilepsy. Epilepsia. 2021;00:1–9.Google Scholar
Hao, N, Jiang, H, Wu, M, et al. Breastfeeding initiation, duration and exclusivity in mothers with epilepsy from south west China. Epilepsy Res. 2017;135:168–75.CrossRefGoogle ScholarPubMed
Roberts, JI, Metcalfe, A, Abdulla, F, et al. Neurologists’ and neurology residents’ knowledge of issues related to pregnancy for women with epilepsy. Epilepsy Behav. 2011;22:358–63.CrossRefGoogle ScholarPubMed
Vazquez, B, Gibson, P, Kustra, R. Epilepsy and women’s health issues: Unmet needs. Survey results from women with epilepsy. Epilepsy Behav. 2007;10:163–9.CrossRefGoogle ScholarPubMed
Eidelman, AI, Schanler, RJ. Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827–e841.Google Scholar
Meek, JY, Feldman-Winter, L, Noble, L. Optimal duration of breastfeeding. Pediatrics. 2020;146(5):e2020021063.CrossRefGoogle ScholarPubMed
Victora, CG, Bahl, R, Barros, AJD, et al. Breastfeeding in the 21st century: Epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475–90.CrossRefGoogle ScholarPubMed
Grubesic, TH, Durbin, KM. A spatial analysis of breastfeeding and breastfeeding support in the United States: The leaders and laggards landscape. J Hum Lact. 2019;35(4):790–800.CrossRefGoogle ScholarPubMed
Gupta, PM, Perrine, CG, Chen, J, Elam-Evans, LD, Flores-Ayala, R. Monitoring the World Health Organization global target 2025 for exclusive breastfeeding: Experience from the United States. Journal of Human Lactation. 2017;33:578–81.CrossRefGoogle ScholarPubMed
Jędrzejczak, J, Kopytek-Beuzen, M, Gawłowicz, J, Stanosz-Sankowska, J, Majkowska-Zwolińska, B. Knowledge of pregnancy and procreation in women with epilepsy of childbearing age: A 16-year comparative study in Poland. Epilepsy Res. 2020;164:106372.CrossRefGoogle Scholar
Meador, KJ, Baker, GA, Browning, N, et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010;75(22):1954–60.CrossRefGoogle ScholarPubMed
Figueiredo, B, Canário, C, Field, T. Breastfeeding is negatively affected by prenatal depression and reduces postpartum depression. Psychol Med. 2014;44(5):927–36.CrossRefGoogle ScholarPubMed
Bjørk, M, Veiby, G, Engelsen, B, Gilhus, NE. Depression and anxiety during pregnancy and the postpartum period in women with epilepsy: A review of frequency, risks and recommendations for treatment. Seizure. 2015;28:33–9.CrossRefGoogle Scholar
Meador, KJ, Baker, GA, Browning, N, et al. Breastfeeding in children of women taking antiepileptic drugs: Cognitive outcomes at age 6 years. JAMA Pediatr. 2014;168(8):729–36.CrossRefGoogle ScholarPubMed
Veiby, G, Engelsen, BA, Gilhus, NE. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding: A prospective cohort study on children of women with epilepsy. JAMA Neurol. 2013;70(11):1367–74.CrossRefGoogle ScholarPubMed
Pennell, PB, Gidal, BE, Sabers, A, Gordon, J, Perucca, E. Pharmacology of antiepileptic drugs during pregnancy and lactation. Epilepsy Behav. 2007;11(3):263–9.CrossRefGoogle ScholarPubMed
Rauchenzauner, M, Kiechl-Kohlendorfer, U, Rostasy, K, Luef, G. Old and new antiepileptic drugs during pregnancy and lactation: Report of a case. Epilepsy Behav. 2011;20(4):719–20.CrossRefGoogle ScholarPubMed
Allegaert, K, van den Anker, J, Naulaers, G, de Hoon, J. Determinants of drug metabolism in early neonatal life. Curr Clin Pharmacol. 2008;2(1):23–9.Google Scholar
Anderson, PO, Sauberan, JB. Modeling drug passage into human milk. Clinical Pharmacology and Therapeutics. 2016;100:42–52.CrossRefGoogle ScholarPubMed
Ito, S, Koren, G. A novel index for expressing exposure of the infant to drugs in breast milk. Br J Clin Pharmacol. 1994;38(2):99–102.CrossRefGoogle ScholarPubMed
Badée, J, Qiu, N, Collier, AC, et al. Characterization of the ontogeny of hepatic UDP-glucuronosyltransferase enzymes based on glucuronidation activity measured in human liver microsomes. J Clin Pharmacol. 2019;59(S1):S42–55.CrossRefGoogle ScholarPubMed
Pennell, PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology. 2003;61(2):35–42.CrossRefGoogle ScholarPubMed
Anderson, PO, Manoguerra, AS, Valdés, V. A review of adverse reactions in infants from medications in breast milk. Clin Pediatr (Phila). 2016;55(3):236–44.CrossRefGoogle Scholar
Birnbaum, AK, Meador, KJ, Karanam, A, et al. Antiepileptic drug exposure in infants of breastfeeding mothers with epilepsy. JAMA Neurol. 2020;77(4):441–50.Google ScholarPubMed
López-Fraile, IP, Cid, AO, Juste, AO, Modrego, PJ. Levetiracetam plasma level monitoring during pregnancy, delivery, and postpartum: Clinical and outcome implications. Epilepsy Behav. 2009;15(3):372–5.CrossRefGoogle ScholarPubMed
Johannessen, SI, Helde, G, Brodtkorb, E. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia. 2005;46(5):775–7.CrossRefGoogle ScholarPubMed
Paret, N, Gouraud, A, Bernard, N, et al. Long-term follow-up of infants exposed to levetiracetam during breastfeeding: Comparison to a control group. Birth Defects Res A Clin Mol Teratol. 2014; 100:537–8.Google Scholar
Ylikotila, P, Ketola, RA, Timonen, S, et al. Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy. Reprod Toxicol. 2015; 57:204–6.CrossRefGoogle ScholarPubMed
Ohman, I, Vitols, S, Tomson, T. Lamotrigine in pregnancy: Pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia. 2000;41(6):709–13.CrossRefGoogle ScholarPubMed
Nordmo, E, Aronsen, L, Wasland, K, Småbrekke, L, Vorren, S. Severe apnea in an infant exposed to lamotrigine in breast milk. Ann Pharmacother. 2009;43:1893–7.CrossRefGoogle Scholar
Yashima, K, Obara, T, Matsuzaki, F, et al. Evaluation of the safety of taking lamotrigine during lactation period. Breastfeed Med. 2021;16:432–8.CrossRefGoogle ScholarPubMed
Soussan, C, Gouraud, A, Portolan, G, et al. Drug induced adverse reactions via breastfeeding: A descriptive study in the French pharmacovigilance database. Eur J Clin Pharmacol. 2014;70(11):1361–6.CrossRefGoogle ScholarPubMed
Btilau, P, Paar, WD, Von Unruh, GE. Pharmacokinetics of oxcarbazepine and l o-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol. 1988;34(3):311–13.Google Scholar
Wegner, I, Edelbroek, P, De Haan, GJ, Lindhout, D, Sander, JW. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. Epilepsia. 2010;51(12):2500–2.CrossRefGoogle ScholarPubMed
Chen, CY, Li, X, Ma, LY, et al. In utero oxcarbazepine exposure and neonatal abstinence syndrome: Case report and brief review of the literature. Pharmacotherapy. 2017;37(7):e71–e75.CrossRefGoogle ScholarPubMed
Kacirova, I, Grundmann, M, Brozmanova, H, Koristkova, B. Monitoring topiramate concentrations at delivery and during lactation. Biomed Pharmacother. 2021;138:111446.CrossRefGoogle ScholarPubMed
Westergren, T, Hjelmeland, K, Kristoffersen, B, Johannessen, SI, Kalikstad, B. Probable topiramate-induced diarrhea in a 2-month-old breast-fed child: A case report. Epilepsy Behav Case Reports. 2014;2(1):22–3.Google Scholar
Kawada, K, Itoh, S, Kusaka, T, Isobe, K, Ishii, M. Pharmacokinetics of zonisamide in perinatal period. Brain Dev. 2002;24(2):95–7.CrossRefGoogle ScholarPubMed
Ando, H, Matsubara, S, Oi, A, et al. Two nursing mothers treated with zonisamide: Should breast-feeding be avoided? J Obstet Gynaecol Res. 2014;40(1):275–8.CrossRefGoogle ScholarPubMed
Ip, S, Chung, M, Raman, G, et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess. 2007;153:1–186.Google Scholar
StahI, M, Neiderud, J, Vinge, E. Thrombocytopenic purpura, and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997;130:1001–3.Google Scholar
Govindan, K, Mandadi, GD. Alopecia in breastfed infant possibly due to mother getting valproate. Indian J Pediatr. 2021;88(5):519–20.CrossRefGoogle ScholarPubMed
Finch, E, Lorber, J. Methaemoglobinaemia in the newborn probably due to phenytoin maternal and infant health outcomes in developed countries. Evid Rep Technol Assess. 2007;153:1–186.Google Scholar
Nau, H, Rating, D. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxy phenobarbital in neonates and infants of epileptic mothers. Eur J Clin Pharmacol. 1980;18:31–42.CrossRefGoogle Scholar
Bar-Oz, B, Nulman, I, Koren, G, Ito, S. Anticonvulsants and breast feeding: A critical review. Paediatr Drugs. 2000;2(2):113–26.CrossRefGoogle ScholarPubMed
Fisher, JB, Edgren, BE, Mammel, MC, et al. Neonatal apnea associated with maternal clonazepam therapy: A case report. Obstet Gynecol. 1985;66(3 Suppl):34S–5S.Google ScholarPubMed
Meador, KJ, Pennell, PB, May, RC, MONEAD Investigator Group. Fetal loss and malformations in the MONEAD study of pregnant women with epilepsy. Neurology. 2020;94(14):e1502–e1511.CrossRefGoogle ScholarPubMed
Tomson, T, Battino, D, Bromley, R, et al. Management of epilepsy in pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord. 2019;21(6):497–517.CrossRefGoogle ScholarPubMed
Lattanzi, S, Cagnetti, C, Foschi, N, Provinciali, L, Silvestrini, M. Lacosamide during pregnancy and breastfeeding. Neurol Neurochir Pol. 2017;51(3):266–9.CrossRefGoogle ScholarPubMed
Drugs and Lactation Database (LactMed) www.ncbi.nlm.nih.gov/books/NBK501922.Google Scholar
Van der Louw, EJTM, Williams, TJ, Henry-Barron, BJ, et al. Ketogenic diet therapy for epilepsy during pregnancy: A case series. Seizure. 2017;45:198–201.CrossRefGoogle ScholarPubMed
Patel, S, Patel, S. The effectiveness of lactation consultants and lactation counselors on breastfeeding outcomes. J Hum Lact. 2015;32(3):530–41.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×